Paid Clinical Trials Columbus

Discover 1,300 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,300

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Columbus OH, Dublin OH, Chillicothe OH, Beavercreek OHshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Columbus OH, Cleveland OH, Morgantown WV, Londonshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

ICXP007Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

PHASE3

Sponsor:

Intercytex

Location:

Columbus OH, Ann Arbor MI, Kittanning PA, Erie PAshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

DexamethasonePerivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting

PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Columbus OH, Chicago IL, Hyattsville MD, Raleigh NCshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Columbus OH, Pontiac MI, London, Charlottesville VAshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

RRx-001RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting

PHASE2

Sponsor:

EpicentRx, Inc.

Location:

Columbus OH, Fort Wayne IN, Ann Arbor MI, Johnson City TNshow 10 more

Code:

NCT05966194

Conditions

Oral Mucositis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RRx-001

Intensity Modulated Radiation Therapy (IMRT)

Cisplatin for injection 100 mg/m2

Influenza VaccineIntralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Recruiting

PHASE1

Sponsor:

Carlo Contreras

Location:

Columbus OH

Code:

NCT04697576

Conditions

Clinical Stage I Cutaneous Melanoma AJCC V8

Clinical Stage IA Cutaneous Melanoma AJCC V8

Clinical Stage IB Cutaneous Melanoma AJCC V8

Clinical Stage II Cutaneous Melanoma AJCC V8

Clinical Stage IIA Cutaneous Melanoma AJCC V8

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ipilimumab

Nivolumab

Pembrolizumab

Quadrivalent Inactivated Influenza Vaccine

Resection

DupilumabA Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Columbus OH, Cincinnati OH, Mentor OH, Ann Arbor MIshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

NaxitamabNaxitamab for High-Risk Neuroblastoma Patients with Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone And/or Bone Marrow

Recruiting

PHASE2

Sponsor:

Y-mAbs Therapeutics

Location:

Columbus OH, Indianapolis IN, Chicago IL, Torontoshow 3 more

Code:

NCT03363373

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

GM-CSF + Naxitamab

PDA TreatmentPREEMIE: Study for Treatment of PDA in Premature Infants

Recruiting

Sponsor:

Merit Medical Systems, Inc.

Location:

Columbus OH, Milwaukee WI, Saint Louis MO, Atlanta GAshow 5 more

Code:

NCT06587282

Conditions

Patent Ductus Arteriosus (PDA)

Eligibility Criteria

Sex: All

Age: 5+

Healthy Volunteers: Not accepted

Interventions

Bloom Micro Occluder System